Long Term Safety of 125 mg Per Day of Oral Azimilide in Patients With Implantable Cardioverter Defibrillator (ICDs)

ClinicalTrials.gov ID: NCT00751738

Public ClinicalTrials.gov record NCT00751738. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Sep 10, 2026, 10:33 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-center, Open-label, Follow-up Study to Assess the Long-term Safety of 125 mg Per Day of Oral Azimilide Dihydrochloride in Patients With an Implantable Cardioverter Defibrillator

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is an open-label, multi-center, long-term, (open-ended) safety study with 125 mg per day of azimilide in patients who completed protocol 2000098.

Study identification

NCT ID: NCT00751738
Recruitment status: Completed
Study type: Interventional
Phase: Phase 3
Lead sponsor: Forest Laboratories; Industry
Enrollment: 330 participants

Conditions and interventions

Conditions

Arrhythmias

Interventions

azimilide dihydrochloride Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 30, 2002
Primary completion: Sep 30, 2005
Completion: Sep 30, 2005
Last update posted: Jan 31, 2017

2002 – 2005

United States locations

U.S. sites: 50
U.S. states: 25
U.S. cities: 46

Facility	City	State	ZIP	Site status
Research Facility	Mobile	Alabama	36608	—
Research Facility	Little Rock	Arkansas	72205	—
Research Facility	La Jolla	California	92037	—
Research Facility	Loma Linda	California	932354	—
Research Facility	Sacramento	California	95819	—
Research Facility	Colorado Springs	Colorado	80910	—
Research Facility	Bridgeport	Connecticut	06610	—
Research Facility	Washington D.C.	District of Columbia	20010	—
Research Facility	Fort Lauderdale	Florida	33308	—
Research Facility	Fort Myers	Florida	33919	—
Research Facility	Jacksonville	Florida	32207	—
Research Facility	Maywood	Illinois	60153	—
Research Facility	Kansas City	Kansas	66160	—
Research Facility	Portland	Maine	04102	—
Research Facility	Baltimore	Maryland	21201	—
Research Facility	Baltimore	Maryland	21204	—
Research Facility	Boston	Massachusetts	02135	—
Research Facility	Burlington	Massachusetts	01805	—
Research Facility	Worcester	Massachusetts	01655	—
Research Facility	Warren Township	New Jersey	07059	—
Research Facility	Brooklyn	New York	11212	—
Research Facility	Johnson City	New York	13797	—
Research Facility	New York	New York	10025	—
Research Facility	New York	New York	10029	—
Research Facility	Rochester	New York	14621	—
Research Facility	Rochester	New York	14642	—
Research Facility	West Orange	New York	07052	—
Research Facility	Williamsville	New York	14221	—
Research Site	Durham	North Carolina	27710	—
Research Facility	Winston-Salem	North Carolina	27157	—
Research Facility	Cincinnati	Ohio	45219	—
Research Facility	Toledo	Ohio	43614	—
Research Facility	Tulsa	Oklahoma	74104	—
Research Facility	Erie	Pennsylvania	16502	—
Research Facility	Hershey	Pennsylvania	17033	—
Research Facility	Lancaster	Pennsylvania	17603	—
Research Facility	Philadelphia	Pennsylvania	19104	—
Research Facility	Charleston	South Carolina	29425	—
Research Site	Columbia	South Carolina	29204	—
Research Facility	Germantown	Tennessee	38138	—
Research Facility	Nashville	Tennessee	37203	—
Research Facility	Dallas	Texas	75226	—
Research Facility	Dallas	Texas	75390	—
Research Facility	Houston	Texas	77030	—
Research Facility	Salt Lake City	Utah	84132	—
Research Facility	Charlottesville	Virginia	22908	—
Research Facility	Fairfax	Virginia	22031	—
Research Facility	Spokane	Washington	99204	—
Research Facility	Green Bay	Wisconsin	54301	—
Research Facility	Milwaukee	Wisconsin	53215	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00751738, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jan 31, 2017 · Synced Sep 10, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00751738 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →